August 17, 2026
This trial aims to find out if the combination of targeted therapy and immunotherapy can provide greater benefit than standard chemotherapy
January 5, 2023
This study is for patients who have aggressive, high-grade tumors that put them at higher risk of recurrence after treatment
January 5, 2023
This trial is evaluating the effect of adding immune system therapy to the usual treatment (chemotherapy and radiation)